Bridget Ory, MD
Infectious Disease · Covington, LANPI 1639226434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $159, 2.9 times the $54 reported in 2019. That places this record below the midpoint for infectious disease clinicians in LA, where the typical reported total is $611.
Across 20 payments — averaging $42.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$191
- AbbVie$144
- Shionogi Inc$125
- Astellas Pharma US Inc$123
- Gilead$122
- Smith+Nephew$63
- plus $92 from 5 others
What the payments were for
- Food & beverage$860100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 5 | $191 |
| AbbVie(2 entities) | 3 | $144 |
| Shionogi Inc | 1 | $125 |
| Astellas Pharma US Inc | 1 | $123 |
| Gilead | 1 | $122 |
| Smith+Nephew | 4 | $63 |
| Solventum Corporation | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$860 in reported general payments places this provider in the 50th percentile of 105 infectious disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 17 | $3,408 |
| CeftriaxoneCeftriaxone Sodium | 12 | $3,050 |
| Doxycycline Hyclate | 15 | $204 |
| Mupirocin | 11 | $111 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Covington
- Carlos HartmannCovington$9K
- Camille BitarCovington$3K
- Michael HillCovington$1K
- Hector Brunet RodriguezShreveport$592K
- Guillermo Padilla-PinedaShreveport$106K
- Eric EhrensingNew Orleans$97K
- Meredith ClementNew Orleans$93K
- Rebecca LillisNew Orleans$60K
- Stephanie TaylorNew Orleans$25K
- Edwin SwiatloNew Orleans$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.